Implications of the FRISCII Trial: Initial Medical Stabilization Followed by an Early Invasive Approach is the Preferred Strategy in Unstable Coronary Syndromes

By Wallentin Lars  

Scandinavian Cardiovascular Journal, Vol. 34, Iss. 1, 2000-05 ,pp. : 4-6

Informa Healthcare

Access to resources Recommend Favorite

Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromes

By Behan Miles W. H.   Fox Susan C.   Heptinstall Stan   Storey Robert F.  

Platelets, Vol. 16, Iss. 2, 2005-03 ,pp. : 73-80

Informa Healthcare

Access to resources Recommend Favorite

The Effect of Glycoprotein IIb/IIIa Receptor Inhibitor on the Microcirculation in Patients Undergoing High-Risk Coronary Stenting; A Prospective, Randomized Study

By Wong Philip   Harding Scott   Inglessis Ignacio   Choi C. Joon   Walters Darren   Chang Yuchiao   Gimelli Giogio   Jang Ik-Kyung  

Journal of Thrombosis and Thrombolysis, Vol. 16, Iss. 3, 2003-12 ,pp. : 163-166

Springer Publishing Company

Access to resources Recommend Favorite

Rationale for the early clinical application of markers of ischemia in patients with suspected acute coronary syndromes

By Jesse Robert   Kukreja Rakesh  

Cardiovascular Toxicology, Vol. 1, Iss. 2, 2001-06 ,pp. : 125-133

Humana Press, Inc

Access to resources Recommend Favorite

Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment

By Iijima Raisuke  

Clinical Research in Cardiology, Vol. 97, Iss. 3, 2008-03 ,pp. : 160-168

Springer Publishing Company

Access to resources Recommend Favorite